Barker C E, Sillis M, Wreghitt T G
Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, England.
J Clin Pathol. 1990 Feb;43(2):163-5. doi: 10.1136/jcp.43.2.163.
The Serodia Myco II particle agglutination test, which the manufacturers claim exclusively detects IgM antibody, was compared with two IgM-specific tests, a mu-capture ELISA, and indirect immunofluorescence for their ability to detect recent Mycoplasma pneumoniae infection. In general there was good agreement among the three tests, all three having similar sensitivity. One hundred and nine (78%) of serum samples gave concordant results in all three assays. Several sera gave positive particle agglutination titres, however, while being negative by the two other assays, and the Serodia Myco II test may not be as specific for detecting M pneumoniae IgM as the other two tests. While the Serodia Myco II test may be a good screening assay, it is unlikely to be a definitive test for M pneumoniae IgM, but may be better than the complement fixation test, particularly in younger patients in whom M pneumoniae IgM is found more frequently.
制造商宣称专门检测IgM抗体的血清学支原体II型颗粒凝集试验,与两种IgM特异性检测方法(μ捕获ELISA和间接免疫荧光法)进行了比较,以评估它们检测近期肺炎支原体感染的能力。总体而言,这三种检测方法之间有良好的一致性,三者敏感性相似。109份(78%)血清样本在所有三种检测中结果一致。然而,有几份血清颗粒凝集试验滴度呈阳性,而另外两种检测方法呈阴性,血清学支原体II型检测对于检测肺炎支原体IgM的特异性可能不如其他两种检测方法。虽然血清学支原体II型检测可能是一种良好的筛查试验,但不太可能是肺炎支原体IgM的确诊试验,但可能比补体结合试验更好,尤其是在更频繁发现肺炎支原体IgM的年轻患者中。